RATIONALE AND OBJECTIVES: The objective of this study was to evaluate the tolerability of hyperpolarized (129)Xe gas inhaled from functional residual capacity and magnetic resonance imaging in healthy subjects and those with pulmonary disease. MATERIALS AND METHODS: Twelve healthy volunteers (mean age, 59 ± 17 years), seven subjects with asthma (mean age, 47 ± 7 years), 10 subjects with chronic obstructive pulmonary disease (mean age, 74 ± 4 years), three subjects with cystic fibrosis (mean age, 27 ± 10 years), and a single subject with radiation-induced lung injury (age, 66 years) were enrolled and evaluated over 43 visits with 136 anoxic inhalations of 500 mL (129)Xe gas mixed with 500 mL (4)He gas. Oxygen saturation and heart rate were monitored during the breath-hold and imaging; subjects were queried for adverse events (AEs) before and immediately following gas inhalation and for 24 hours after the last dose. RESULTS: No subjects withdrew from the study or reported serious, hypoxic, or severe AEs. Over the course of 136 dose administrations, two mild AEs (1%) were reported in two different subjects (two of 33 [6%]). One of these AEs (light-headedness) was temporally related and judged as possibly related to (129)Xe administration and resolved without treatment within 2 minutes. Statistically significant but clinically insignificant changes in oxygen saturation and heart rate were observed after inhalation (P < .001), and both resolved 1 minute later, with no difference between subject groups. CONCLUSIONS: Inhalation of hyperpolarized (129)Xe gas and subsequent magnetic resonance imaging were well tolerated in healthy subjects and ambulatory subjects with obstructive and restrictive pulmonary disease.
RATIONALE AND OBJECTIVES: The objective of this study was to evaluate the tolerability of hyperpolarized (129)Xe gas inhaled from functional residual capacity and magnetic resonance imaging in healthy subjects and those with pulmonary disease. MATERIALS AND METHODS: Twelve healthy volunteers (mean age, 59 ± 17 years), seven subjects with asthma (mean age, 47 ± 7 years), 10 subjects with chronic obstructive pulmonary disease (mean age, 74 ± 4 years), three subjects with cystic fibrosis (mean age, 27 ± 10 years), and a single subject with radiation-induced lung injury (age, 66 years) were enrolled and evaluated over 43 visits with 136 anoxic inhalations of 500 mL (129)Xe gas mixed with 500 mL (4)He gas. Oxygen saturation and heart rate were monitored during the breath-hold and imaging; subjects were queried for adverse events (AEs) before and immediately following gas inhalation and for 24 hours after the last dose. RESULTS: No subjects withdrew from the study or reported serious, hypoxic, or severe AEs. Over the course of 136 dose administrations, two mild AEs (1%) were reported in two different subjects (two of 33 [6%]). One of these AEs (light-headedness) was temporally related and judged as possibly related to (129)Xe administration and resolved without treatment within 2 minutes. Statistically significant but clinically insignificant changes in oxygen saturation and heart rate were observed after inhalation (P < .001), and both resolved 1 minute later, with no difference between subject groups. CONCLUSIONS: Inhalation of hyperpolarized (129)Xe gas and subsequent magnetic resonance imaging were well tolerated in healthy subjects and ambulatory subjects with obstructive and restrictive pulmonary disease.
Authors: Mu He; Scott H Robertson; S Sivaram Kaushik; Matthew S Freeman; Rohan S Virgincar; John Davies; Jane Stiles; William M Foster; H Page McAdams; Bastiaan Driehuys Journal: Magn Reson Imaging Date: 2015-04-30 Impact factor: 2.546
Authors: Jeff Kammerman; Andrew D Hahn; Robert V Cadman; Annelise Malkus; David Mummy; Sean B Fain Journal: Magn Reson Med Date: 2020-03-11 Impact factor: 4.668
Authors: Mu He; S Sivaram Kaushik; Scott H Robertson; Matthew S Freeman; Rohan S Virgincar; H Page McAdams; Bastiaan Driehuys Journal: Acad Radiol Date: 2014-09-26 Impact factor: 3.173
Authors: Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland Journal: Pediatr Radiol Date: 2016-08-05
Authors: Kun Qing; John P Mugler; Talissa A Altes; Yun Jiang; Jaime F Mata; G Wilson Miller; Iulian C Ruset; F William Hersman; Kai Ruppert Journal: NMR Biomed Date: 2014-08-22 Impact factor: 4.044
Authors: Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods Journal: Eur Respir J Date: 2019-05-02 Impact factor: 16.671
Authors: Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain Journal: Eur J Radiol Date: 2016-09-16 Impact factor: 3.528
Authors: Zackary I Cleveland; Rohan S Virgincar; Yi Qi; Scott H Robertson; Simone Degan; Bastiaan Driehuys Journal: NMR Biomed Date: 2014-05-12 Impact factor: 4.044
Authors: Matthew M Willmering; Peter J Niedbalski; Hui Wang; Laura L Walkup; Ryan K Robison; James G Pipe; Zackary I Cleveland; Jason C Woods Journal: Magn Reson Med Date: 2019-12-01 Impact factor: 4.668
Authors: Lucia Flors; John P Mugler; Eduard E de Lange; Grady W Miller; Jaime F Mata; Nick Tustison; Iulian C Ruset; F William Hersman; Talissa A Altes Journal: J Thorac Imaging Date: 2016-09 Impact factor: 3.000